Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

por Mazzocco, P, Barthélémy, C, Kaloshi, G, Lavielle, M, Ricard, D, Idbaih, A, Psimaras, D, Renard, M‐A, Alentorn, A, Honnorat, J, Delattre, J‐Y, Ducray, F, Ribba, B
Publicado 2015

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations

por Labussière, M, Di Stefano, A L, Gleize, V, Boisselier, B, Giry, M, Mangesius, S, Bruno, A, Paterra, R, Marie, Y, Rahimian, A, Finocchiaro, G, Houlston, R S, Hoang-Xuan, K, Idbaih, A, Delattre, J-Y, Mokhtari, K, Sanson, M
Publicado 2014

European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN

por Blay, J.-Y., Casali, P., Bouvier, C., Dehais, C., Galloway, I., Gietema, J., Halámková, J., Hindi, N., Idbaih, A., Kinloch, E., Klümpen, H.-J., Kolarova, T., Kopeckova, K., Lovey, J., Magalhaes, M., Oselin, K., Piperno-Neumann, S., Ravnsbaek, A., Rogasik, M., Safwat, A., Scheipl, S., Seckl, M., Taylor, J., Temnyk, M., Trama, A., Urbonas, M., Wartenberg, M., Weinman, A.
Publicado 2021

Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222

por Enciso-Mora, V, Hosking, F J, Di Stefano, A L, Zelenika, D, Shete, S, Broderick, P, Idbaih, A, Delattre, J-Y, Hoang-Xuan, K, Marie, Y, Labussière, M, Alentorn, A, Ciccarino, P, Rossetto, M, Armstrong, G, Liu, Y, Gousias, K, Schramm, J, Lau, C, Hepworth, S J, Schoemaker, M, Strauch, K, Müller-Nurasyid, M, Schreiber, S, Franke, A, Moebus, S, Eisele, L, Swerdlow, A, Simon, M, Bondy, M, Lathrop, M, Sanson, M, Houlston, R S
Publicado 2013